Dive into the latest insights from our top experts and stay updated with the most recent developments in market access.
关于我们
For nearly two decades MMIT has been solely focused on solving the “what and why” of drug coverage and has been a trusted, go-to-market partner to pharma companies, payers and providers. We believe that patients who need lifesaving treatments shouldn’t face delays because accessing drugs can be confusing. As the leading provider of market access data, analytics and insights, our expert teams of clinicians, data specialists and market researchers provide clarity and confidence so that our clients can make better decisions. Divisions of MMIT include AIS Health, creator of the Directory of Health Plans and leading healthcare publications; Zitter Health Insights, a preeminent provider of market access insights and solutions for specialty drugs; RJ Health, the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit; and The Dedham Group, a U.S. market access oncology and specialty therapeutics consultancy offering research, data analytics and strategy formulation services to the life sciences industry.
- 网站
-
https://www.mmitnetwork.com
MMIT (Managed Markets Insight & Technology)的外部链接
- 所属行业
- 信息服务
- 规模
- 201-500 人
- 总部
- Yardley，Pennsylvania
- 类型
- 私人持股
- 领域
- Formulary, Policy & Restriction Transparency、Mobile Formulary Search Application、Launch Commercialization Guidance和Formulary Management & Publishing
地点
MMIT (Managed Markets Insight & Technology)员工
动态
-
Is your therapy brand launch strategy stuck in the past? https://ow.ly/A6E950TRYtg Discover how a mid-sized pharma company slashed data lag, achieved cost savings, and enhanced decision-making with MMIT’s API. Don’t miss out on these game-changing insights! Download the Use Case by clicking the link in this post. #PharmaCompanies #MarketAccess #MarketAccessStrategy
-
-
Are you seeking high-value healthcare professionals for your therapy? Get a sample HCP targeting report in just three easy clicks. ?? https://ow.ly/ZnXv50TVCQl
-
-
Disease state education isn’t just for first-to-market therapies. https://ow.ly/RIOI50SUY63 In BioPharma Dive, Dr. Shrinal Patel and Carolyn Zele share how and why pharma manufacturers should invest in physician education in peer-to-peer networks. #MarketAccess #PharmaManufacturers #Pharma #Physicians
-
-
Payer pushback on the high cost of hemophilia cell and gene therapies is reflected in the quality of their coverage. https://ow.ly/xEFX50TNY65 MMIT’s Andrew Rouff discusses the factors behind the slow uptake of these curative therapies in this blog. Click the link in this post for the insights. #Hemophilia #HemophiliaTreatments #CGTs
-
-
New in Health Plan Weekly: https://hubs.ly/Q02Zcj0f0 Aetna projects big ACA drop, Oz and Kennedy picks fuel industry-wide uncertainty, value-based care's slow-but-steady rise, and more top stories.
-
-
Commercialization can be particularly difficult for smaller manufacturers. https://ow.ly/bAil50Ubm7z This case study details how one small biopharma company partnered with MMIT to track coverage and restrictions for its first commercial launch in the rare disease space. Access the case study at the link in this post. #Biopharma #RareDiseases #Pharmaceuticals #LifeSciences
-
-
New in today's Radar on Medicare Advantage: https://hubs.ly/Q02Z4twF0 MA gets an ally in Dr. Oz, the odds of an MA rebate overhaul in a second Trump administration, the mid-AEP marketing changes raising brokers' eyebrows, and more top stories.
-
-
Integrating real-world datasets with payer policy and restriction data reveals the full scope of the patient journey. https://ow.ly/IRgL50U8huJ In Drug Channels Institute, an HMP Global Company, MMIT’s Kala Bala and Dinesh Kabaleeswaran discuss the evolution of market access and what pharma can accomplish with AI and predictive analytics. #MarketAccess #PharmaInnovation #PredictiveAnalytics #PatientJourney
-
-
https://ow.ly/CKG750UapAa Discover how leading pharmaceutical companies leverage MMIT's powerful Analytics platform to gain seamless access to comprehensive formulary information, medical policies, and restriction details. Download our case studies to see how our user-friendly technology drives industry success at the link in this post.
-